177 related articles for article (PubMed ID: 25874961)
1. Minocycline for Recurrent and/or Chronic Erythema Nodosum Leprosum.
Narang T; Sawatkar GU; Kumaran MS; Dogra S
JAMA Dermatol; 2015 Sep; 151(9):1026-8. PubMed ID: 25874961
[No Abstract] [Full Text] [Related]
2. Necrotic erythema nodosum leprosum as the first manifestation of borderline lepromatous leprosy.
Tourlaki A; Marzano AV; Gianotti R; Fiallo P; Nunzi E; Alessi E
Arch Dermatol; 2008 Jun; 144(6):818-20. PubMed ID: 18559789
[No Abstract] [Full Text] [Related]
3. [Study of erythema nodosum leprosum].
Nguyen VU
Ann Dermatol Venereol; 1994; 121(2):194-6. PubMed ID: 7979039
[TBL] [Abstract][Full Text] [Related]
4. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine.
Schreuder PA; Naafs B
Lepr Rev; 2003 Dec; 74(4):386-9. PubMed ID: 14750585
[No Abstract] [Full Text] [Related]
5. Lepromatous leprosy in Saudi female from central region.
al-Majed S
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
[TBL] [Abstract][Full Text] [Related]
6. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
Pal D
Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
[TBL] [Abstract][Full Text] [Related]
7. Target/therapies for chronic recurrent erythema nodosum leprosum.
Thangaraju P; Varthya SB; Venkatesan S
Indian J Pharmacol; 2020; 52(3):222-226. PubMed ID: 32874007
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study.
Kaur I; Dogra S; Narang T; De D
Australas J Dermatol; 2009 Aug; 50(3):181-5. PubMed ID: 19659979
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of minocycline and clofazimine in chronic and recurrent erythema nodosum leprosum-A randomized clinical trial.
Hanumanthu V; Thakur V; Narang T; Dogra S
Dermatol Ther; 2021 Nov; 34(6):e15125. PubMed ID: 34490707
[TBL] [Abstract][Full Text] [Related]
10. Erythema nodosum leprosum associated with minocycline.
Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
[TBL] [Abstract][Full Text] [Related]
11. An uncommon variant of erythema nodosum leprosum responding well to methotrexate: Report of two cases.
Rani S; Singh S; Agrawal D; Sardana K; Ahuja A
Trop Doct; 2021 Oct; 51(4):569-572. PubMed ID: 34102925
[TBL] [Abstract][Full Text] [Related]
12. Bullous Erythema Nodosum Leprosum masquerading as systemic onset juvenile idiopathic arthritis: A case report.
Pradhan S; Prasad Nayak B; Padhi T; Sethy M
Lepr Rev; 2015 Dec; 86(4):387-90. PubMed ID: 26964436
[No Abstract] [Full Text] [Related]
13. Pulse dexamethasone, oral steroids and azathioprine in the management of erythema nodosum leprosum.
Mahajan VK; Sharma NL; Sharma RC; Sharma A
Lepr Rev; 2003 Jun; 74(2):171-4. PubMed ID: 12862259
[No Abstract] [Full Text] [Related]
14. Erythema nodosum leprosum: reactional leprosy.
Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
[TBL] [Abstract][Full Text] [Related]
15. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
Walker SL; Saunderson P; Kahawita IP; Lockwood DN
Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
[No Abstract] [Full Text] [Related]
16. Can etanercept be an option in management of recurrent steroid-dependent erythema nodosum leprosum? A retrospective study of six patients.
Sahani MK; Asati DP; Kaur M; Patra S
Indian J Dermatol Venereol Leprol; 2022; 88(2):243-246. PubMed ID: 34877848
[No Abstract] [Full Text] [Related]
17. Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times.
Sachdeva S; Sardana K; Kumari R; Bhogar K; Khurana A; Malhotra P
Int J Dermatol; 2022 Nov; 61(11):e441-e443. PubMed ID: 35405022
[No Abstract] [Full Text] [Related]
18. Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study.
Narang T; Ashraf R; Kaushik A; Dogra S
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e917-e919. PubMed ID: 34365679
[No Abstract] [Full Text] [Related]
19. Treatment of recurrent erythema nodosum leprosum with infliximab.
Faber WR; Jensema AJ; Goldschmidt WF
N Engl J Med; 2006 Aug; 355(7):739. PubMed ID: 16914716
[No Abstract] [Full Text] [Related]
20. Successful treatment of erythema nodosum leprosum with apremilast.
Abril-Pérez C; Palacios-Diaz RD; Navarro-Mira MÁ; Botella-Estrada R
Dermatol Ther; 2022 Mar; 35(3):e15258. PubMed ID: 34890096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
